Albemarle Corporation Unveils Investor Presentation Highlighting 2024 Financial Performance and Strategic Initiatives

Reuters
20 May
Albemarle Corporation Unveils Investor Presentation Highlighting 2024 Financial Performance and Strategic Initiatives

Albemarle Corporation has released its May 2025 Investor Presentation, highlighting key financial and operational metrics. The presentation details Albemarle's performance, including a reported FY 2024 net sales figure of $5.4 billion and an adjusted EBITDA margin of approximately 21%. The company operates globally with around 8,300 employees, serving approximately 1,900 customers across 70 countries. Albemarle maintains over 25 production and R&D facilities and holds more than 1,600 active patents. The presentation underscores Albemarle's role as a global leader in transforming essential resources. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Albemarle Corporation published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10